Evidence map›Paper›PMID 29769995›Full record

ArticleCanada communicable disease report = Releve des maladies transmissibles au Canada2016

Vaccine acceptance, hesitancy and refusal in Canada: Challenges and potential approaches.

E Dubé, J A Bettinger, W A Fisher, M Naus, S M Mahmud, T Hilderman

Abstract readEditorial
In one paragraph

Article in Canada communicable disease report = Releve des maladies transmissibles au Canada, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Sociodemographic factors associated with vaccine hesitancy in the South Asian community in Canada.Canadian journal of public health = Revue canadienne de sante publique · 2024
    Article
  8. Vaccines · 2024
    Article
  9. Article
  10. Public health challenges · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

E DubéInstitut national de santé publique du Québec, Québec, QC.
J A BettingerVaccine Evaluation Center, BC Children's Hospital, University of British Columbia, Vancouver, BC.
W A FisherUniversity of Western Ontario, London, ON.
M NausBC Centre for Disease Control, Vancouver, BC.
S M MahmudDepartment of Community Health Sciences, University of Manitoba, Winnipeg, MB.
T HildermanManitoba Health, Winnipeg, MB.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

"Vaccine hesitancy" is a concept used frequently in vaccination discourse and is challenging previously held perspective that individual vaccination attitudes and behaviours are a simple dichotomy of accept or reject. Given the importance of achieving high vaccine coverage in Canada to avoid vaccine preventable diseases and their consequences, vaccine hesitancy is an important issue that needs to be addressed. This article describes the scope and causes of vaccine hesitancy in Canada and proposes potential approaches to address it.

Identifiers

PMID29769995
PMCPMC5757714

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.